#apheresis

Only 5 nosebleeds and hella procedures + tests later....

Ever so casually has these on her 2025 bingo board..... • 4 hour nosebleed (5 nosebleeds total) • 5 days of bpm at 170 or above (maxed at 211) • an hour ambulance ride • a three hospital admission situation (OR, Knox, Lexington KY) • airlifted almost three hours away (taking a car), airlift was 45min to 90min - and I'm horribly scared of flying so also ° first ever flight • has a 7 unit (7 bags of blood) exchange transfusion/apheresis (there were only 3 probes for the procedure but because of my vasculature? Did the insertions twice. So that's six probes total) • minor venous thrombosis in my left arm after said treatment • oh and I coughed up some hella phlegm from that nosebleed ° all after encountering both vagus nerve AND sciatic nerve damage at the beginning of February from an impromptu port surgery that happened She Brave, She Sturdy, She's just "Built different" (idk y'all 🤷🏾‍♀️

First admitted July 1st, Disability Awareness Month

Nosebleed 1. Lasted 4hrs, started July 3rd Nosebleed 2. Lasted 2hrs, started July 10th Nosebleed 3. Lasted 3hrs, started July 11th Nosebleed 4. Lasted 3hrs, started July 13th Nosebleed 5. Lasted 2hrs, started July 16th Absolutely exhausted. Definitely a trooper. Ever unwavering. They don't call us Sickle Cell Warriors for no reason ⚘️

Exchange Transfusion / Trialysis Probe Removal

( Sickest I've been in like 27 of my 29 years 🫠)

⚘️ Raising Funds for The Rest of 2025 Due to This ⚘️

Sickle Cell Fact Sheet 1 // Sickle Cell Fact Sheet 2

The global demand for Apheresis Equipment was valued at USD 2815.2 Million in 2023 and is expected to reach USD 7498.6 Million in 2032, growing at a CAGR of 11.50% between 2024 and 2032.Apheresis, a medical technology that involves the extraction of various components of blood, is a critical procedure in treating a variety of medical conditions. The equipment used for apheresis is specialized and designed to separate blood into its individual components: plasma, platelets, white blood cells, and red blood cells. The global apheresis equipment market has seen significant growth due to advancements in technology, increasing prevalence of chronic diseases, and rising demand for blood components.

Browse the full report at https://www.credenceresearch.com/report/apheresis-equipment-market

Market Dynamics

The apheresis equipment market is driven by several factors:

1. Rising Prevalence of Chronic Diseases: Chronic diseases such as cancer, autoimmune disorders, and cardiovascular diseases often require apheresis as part of treatment. The growing incidence of these conditions is a primary driver for the market.

2. Technological Advancements: Innovations in apheresis technology have improved the efficiency and safety of procedures. Automated apheresis machines, for instance, have enhanced the precision of blood component separation, reducing procedure time and increasing patient comfort.

3. Tncreasing Demand for Plasm: Plasma-derived therapies are essential for treating various medical conditions, including hemophilia and immune deficiencies. The rising demand for plasma has propelled the need for apheresis equipment.

4. Growing Number of Blood Donations: The need for blood and its components in medical treatments and surgeries has led to an increase in blood donations. Apheresis equipment is crucial in the collection of specific blood components from donors.

Market Segmentation

The apheresis equipment market can be segmented based on product type, procedure, technology, application, and end-user.

1. By Product Type: - Disposable Apheresis Kits: These kits include all necessary components for apheresis procedures and are designed for single-use to prevent cross-contamination. - Apheresis Machines: These are the primary devices used to perform apheresis procedures.

2. By Procedure: - Plasmapheresis: The removal of plasma from the blood. - Plateletpheresis: The extraction of platelets. - Leukapheresis: The removal of white blood cells. - Erythrocytapheresis: The removal of red blood cells.

3. By Technology: - Centrifugation: This technology separates blood components based on density. - Membrane Filtration: This method uses filters to separate components based on size.

4. By Application: - Neurology: For treating neurological disorders like multiple sclerosis. - Hematology: For managing blood disorders. - Oncology: For treating cancer patients, especially those undergoing chemotherapy. - Renal Diseases: For managing kidney-related conditions.

5. By End-User: - Hospitals: The largest end-users of apheresis equipment. - Blood Donation Centers: Utilize apheresis equipment for collecting blood components. - Research Institutes: Use apheresis in various research and clinical trials.

Regional Analysis

The apheresis equipment market is geographically diverse, with key regions including North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

- North America: Dominates the market due to advanced healthcare infrastructure, high prevalence of chronic diseases, and significant research and development activities. - Europe: Follows North America, with increasing healthcare expenditure and technological advancements driving market growth. - Asia-Pacific: Expected to witness the highest growth rate due to improving healthcare facilities, rising awareness about apheresis procedures, and increasing medical tourism. - Latin America and the Middle East & Africa: These regions are also experiencing growth due to rising healthcare investments and an increasing focus on improving medical facilities.

Competitive Landscape

The apheresis equipment market is highly competitive, with key players focusing on product innovation, strategic partnerships, and mergers & acquisitions to strengthen their market position. Major companies include Haemonetics Corporation, Terumo BCT, Inc., Fresenius Kabi, Asahi Kasei Medical Co., Ltd., and Cerus Corporation.

Key Players

B.Braun Melsungen AG

Haemonetics Corporation

Fresenius Kabi AG

Asahi Kasei Medical Co., Ltd.

Terumo BCT, Inc.

Mallinckrodt

Nikkiso Europe GmbH

Others

Segmentation

By Apheresis Equipment Types:

Plasmapheresis Equipment

Plateletpheresis Equipment

Leukapheresis Equipment

Erythrocytapheresis Equipment

Therapeutic Apheresis Equipment

By Technology-Based Segments:

Centrifugation Apheresis Equipment

Membrane Filtration Apheresis Equipment

By Application-Specific Apheresis Equipment:

Renal (Kidney) Apheresis Equipment

Neurological Apheresis Equipment

Hematological Disorders Apheresis Equipment

Autoimmune Disorders Apheresis Equipment

By End-User:

Hospitals and Clinics

Blood Donation Centers

Ambulatory Surgical Centers (ASCs)

Research and Academic Institutes

By Procedure Type:

Donor Apheresis Equipment

Therapeutic Apheresis Equipment

By Disposable vs. Reusable Apheresis Equipment:

Disposable Apheresis Equipment

Reusable Apheresis Equipment

By Region

North America

The U.S.

Canada

Mexico

Europe

Germany

France

The U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/apheresis-equipment-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: [email protected]

Overview of This Study:

This research employed a large number of primary and secondary sources. In order to determine the segmentation kinds, industry trends, major players, competitive landscape, important market dynamics, and major player strategies, the research procedure entailed analyzing a variety of industry-affecting aspects.

Major Growth Driving Factors:

The growing number of injury cases and the rising prevalence of chronic diseases, the growing demand from biopharmaceutical companies for source plasma, the growing demand for blood components and growing concerns about blood safety, the rise in complex surgical procedures, and the favorable reimbursement for apheresis procedures are the main factors driving the market for apheresis.

However, a number of factors are anticipated to restrict market growth in the upcoming years, including the high cost of therapeutic apheresis procedures and devices, the rental model for apheresis device installation, the low number of blood donations using apheresis due to lack of awareness, and the strict donor recruitment criteria.

Revenue Growth Forecast:

The global apheresis market boasts a total value of $1.7 billion in 2019 and is projected to register a growth rate of 8.1% to reach a value of $2.7 billion by 2025.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=950

Global Market Segmentation:

Throughout the projection period, the centrifugation technology segment is anticipated to develop at the greatest CAGR.

The apheresis market is divided into membrane separation technology and centrifugation technology segments based on technology. Over the course of the projection period, the centrifugation segment is anticipated to increase at the greatest CAGR. The advantages of centrifugation over membrane separation, namely its great efficiency and capacity to separate all forms of blood components, can be credited for this rapid expansion.

Over the course of the forecast period, the photopheresis segment is anticipated to increase at the greatest CAGR.

The apheresis market is divided into segments based on application, including photopheresis, erythrocytapheresis, leukapheresis, plateletpheresis, and plasmapheresis. Over the course of the projected period, the photopheresis is anticipated to increase at the fastest rate. The increased incidence of blood diseases and the growing need for photopheresis in the treatment of organ transplant rejection are responsible for this segment's rapid rise.

End User:

Throughout the projection period, the hospitals and transfusion centers sector is anticipated to grow at the fastest rate.

The apheresis market has been divided into hospitals and transfusion facilities, blood collection facilities and blood component suppliers, and other end users based on end user. The segment with the highest predicted compound annual growth rate (CAGR) during the projected period is hospitals and transfusion centers. This segment's rapid expansion can be ascribed to the expanding indications of therapeutic apheresis, increased awareness of apheresis as a therapy, and the growing use of apheresis in the treatment of numerous diseases.

Revenue Growth Forecast:

In 2018, North America held the biggest market share.

In 2018, North America held the greatest share of the market for apheresis, followed by Europe. The region's substantial share can be ascribed to its easier access to cutting-edge blood collection technologies, its well-established healthcare infrastructure, and the growing number of top apheresis businesses operating in the nation.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=950

Global Key Players:

The prominent players in this market are Terumo BCT, Inc. (US), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (US), Asahi Kasei Medical Co. Ltd. (Japan), B. Braun Melsungen AG (Germany), Baxter International Inc. (US), Cerus Corporation (US), Kaneka Corporation (Japan), Kawasumi Laboratories, Inc. (Japan), Nikkiso Co., Ltd. (Japan), Macopharma SA (France), Miltenyi Biotec (Germany), Otsuka Holdings Co. Ltd. (Japan), Medica S.p.A. (Italy), Mallinckrodt plc (Ireland), Medicap Clinic GmbH (Germany), Lmb Technologies GmbH (Germany), Bioelettronica (Italy), Infomed (Switzerland), Cytosorbents Corporation (US), and Toray Medical Co. Ltd. (Japan), among other key players.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Growth Driving Factors:

The market for apheresis is primarily driven by the rising prevalence of chronic diseases and the growing number of and injury cases, the increasing demand for source plasma from biopharmaceutical companies, the rising demand for blood components and growing concerns regarding blood safety, the increase in the number of complex surgical procedures, and the favorable reimbursement for apheresis procedures.

However, the high cost of apheresis devices & therapeutic apheresis procedures and installation of apheresis devices through the rental model, fewer blood donations using apheresis due to lack of awareness, and the stringent donor recruitment criteria are factors expected to limit market growth to a certain extent in the coming years.

Critical Questions this Report Answers:

# Where will these developments take the industry in the mid-to-long term? # Who are the major end users in the apheresis market, and what are the benefits they avail by implementing apheresis technology? # What are the recent trends in the apheresis market? # What are the major market dynamics and their impact on overall market growth? # What is the global scenario of the apheresis market?

Projected Surge in Revenue:

The global apheresis market is projected to reach USD 2.7 billion by 2025 from USD 1.7 billion in 2019, at a CAGR of 8.1% during the forecast period.

Get the Sample for More Detailed Information@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=950

End Users:

The hospitals and transfusion centers segment is expected to grow at the highest CAGR during the forecast period

On the basis of end user, the apheresis market has been segmented into blood collection centers and blood component providers, hospitals and transfusion centers, and other end users. The hospitals and transfusion centers segment is estimated to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to the increasing adoption of therapeutic apheresis in the treatment of various diseases, growing indications of therapeutic apheresis, and rising awareness of apheresis as a therapy.

Global Geographical Growth Scenario:

North America accounted for the largest market share in 2018

North America accounted for the largest share of the apheresis market in 2018, followed by Europe. The large share of this region can be attributed to easier accessibility to advanced blood collection technologies, the presence of established healthcare infrastructure, and the increasing presence of leading apheresis companies in the country.

Key Players:

The prominent players in this market are Terumo BCT, Inc. (US), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (US), Asahi Kasei Medical Co. Ltd. (Japan), B. Braun Melsungen AG (Germany), Baxter International Inc. (US), Cerus Corporation (US), Kaneka Corporation (Japan), Kawasumi Laboratories, Inc. (Japan), Nikkiso Co., Ltd. (Japan), Macopharma SA (France), Miltenyi Biotec (Germany), Otsuka Holdings Co. Ltd. (Japan), Medica S.p.A. (Italy), Mallinckrodt plc (Ireland), Medicap Clinic GmbH (Germany), Lmb Technologies GmbH (Germany), Bioelettronica (Italy), Infomed (Switzerland), Cytosorbents Corporation (US), and Toray Medical Co. Ltd. (Japan), among other key players.

You Can Also Connect With Our Experts@ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=950

Recent Developments:

# In July 2019, Baxter International Inc. (US) launched the PrisMax system in the US.

# In June 2019, Toray Medical Co. Ltd. (Japan) launched the TORAMYXIN device in the European region.

# In October 2019, Terumo BCT (US) collaborated with the UniCAR-Therapy Bio-Medicine Technology Co. (China). This collaboration aimed at advancing CAR T-cell therapies by creating a new Shanghai Center of Excellence. This development also helped Terumo widen its applications of apheresis and leukapheresis procedures.

# In August 2017, Fresenius Medical Care (Germany) acquired NxStage Medical, Inc. (US). This acquisition enabled Fresenius Medical Care to further expand its presence in the renal care and critical care area.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Apheresis Market See Incredible Growth 2022-2032 | Terumo BCT, Fresenius SE & Co. KGaA, Haemonetics Corp, Nikkiso Co., Ltd.

Global Apheresis Market report 2023 to 2032 studies the Apheresis with many aspects of the industry such as the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. Find the complete Apheresis Market analysis segmented by companies, region, type and applications in the…